Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer.

作者: Ralph G. Zinner , Frank V. Fossella , Gregory W. Gladish , Bonnie S. Glisson , George R. Blumenschein

DOI: 10.1002/CNCR.21480

关键词: GastroenterologyMedicineB vitaminsNeutropeniaTolerabilityPerformance statusChemotherapyRegimenInternal medicineSurgeryPemetrexedCarboplatin

摘要: … 3 had toxicity (two with Grade 2 fatigue and one with dyspnea/… The other 2 of 5 stopped after course 8 with Grade 2 fatigue. … 7 with Grade 3 fatigue and neutropenic pneumonia. Three …

参考文章(34)
Edward C. Taylor, Design and Synthesis of Inhibitors of Folate Dependent Enzymes as Antitumor Agents Advances in Experimental Medicine and Biology. ,vol. 338, pp. 387- 408 ,(1993) , 10.1007/978-1-4615-2960-6_80
E A Rayl, K A Shackelford, L L Habeck, V F Patel, L G Mendelsohn, V J Chen, S B Gates, R M Schultz, M Ratnam, J R Bewley, S L Andis, W C MacKellar, D J Soose, B A Moroson, W Kohler, L S Gossett, G P Beardsley, C Shih, LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes Cancer Research. ,vol. 57, pp. 1116- 1123 ,(1997)
Jean Klastersky, Jean-Paul Sculier, Hendrik Lacroix, Gérard Dabouis, Gérard Bureau, P Libert, Michel Richez, Pol Ravez, Guy Vandermoten, Jacques Thiriaux, None, A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. Journal of Clinical Oncology. ,vol. 8, pp. 1556- 1562 ,(1990) , 10.1200/JCO.1990.8.9.1556
C J Langer, J C Leighton, R L Comis, P J O'Dwyer, C A McAleer, C A Bonjo, P F Engstrom, S Litwin, R F Ozols, Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis. Journal of Clinical Oncology. ,vol. 13, pp. 1860- 1870 ,(1995) , 10.1200/JCO.1995.13.8.1860
J Klastersky, J P Sculier, G Bureau, P Libert, P Ravez, G Vandermoten, J Thiriaux, J Lecomte, R Cordier, G Dabouis, Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium. Journal of Clinical Oncology. ,vol. 7, pp. 1087- 1092 ,(1989) , 10.1200/JCO.1989.7.8.1087
Maurie Markman, Alexander Kennedy, Kenneth Webster, Paul Elson, Gertrude Peterson, Barbara Kulp, Jerome Belinson, Clinical Features of Hypersensitivity Reactions to Carboplatin Journal of Clinical Oncology. ,vol. 17, pp. 1141- 1141 ,(1999) , 10.1200/JCO.1999.17.4.1141
C. Manegold, U. Gatzemeier, J. von Pawel, R. Pirker, R. Malayeri, J. Blatter, K. Krejcy, Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, Pemetrexed disodium, ALIMTA™ and cisplatin: A multicenter phase II trial Annals of Oncology. ,vol. 11, pp. 435- 440 ,(2000) , 10.1023/A:1008336931378
Ian E. Smith, Mary E.R. O’Brien, Denis C. Talbot, Marianne C. Nicolson, Janine L. Mansi, Tamas F. Hickish, Alison Norton, Susan Ashley, Duration of Chemotherapy in Advanced Non–Small-Cell Lung Cancer: A Randomized Trial of Three Versus Six Courses of Mitomycin, Vinblastine, and Cisplatin Journal of Clinical Oncology. ,vol. 19, pp. 1336- 1343 ,(2001) , 10.1200/JCO.2001.19.5.1336
Karen Kelly, John Crowley, Paul A. Bunn, Cary A. Presant, Patra K. Grevstad, Carol M. Moinpour, Scott D. Ramsey, Antoinette J. Wozniak, Geoffrey R. Weiss, Dennis F. Moore, Valerie K. Israel, Robert B. Livingston, David R. Gandara, Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial Journal of Clinical Oncology. ,vol. 19, pp. 3210- 3218 ,(2001) , 10.1200/JCO.2001.19.13.3210
R. Thödtmann, H. Depenbrock, H. Dumez, J. Blatter, R. D. Johnson, A. van Oosterom, A.-R. Hanauske, Clinical and Pharmacokinetic Phase I Study of Multitargeted Antifolate (LY231514) in Combination With Cisplatin Journal of Clinical Oncology. ,vol. 17, pp. 3009- 3016 ,(1999) , 10.1200/JCO.1999.17.10.3009